Vir Biotechnology

Vir Biotechnology is a clinical-stage immunology company dedicated to combining immunological insights with cutting-edge technology to treat and prevent serious infectious diseases. Vir Biotechnology adopts a multi-program, multi-technology platform approach assembled through internal development, collaboration, and acquisition. The company has an industry-leading management team, board of directors, and scientific advisors with extensive experience in the fields of immunology and infectious diseases, specializing in all processes from early research of candidate products to clinical trials, regulatory approval, and eventual commercialization.